Knowledge Management: Unlocking Value in Pharma Life Sciences

Though the concept of the Knowledge-Based Organization (KBO) has existed since the early 1990s 1, FORTUNE 500 companies are losing roughly $32 billion a year by failing to manage knowledge effectively.2 With the increasing relevance of data analytics, Pharmaceutical and Life Sciences executives are becoming more datadriven (see Figure 1) and discovering that effective knowledge management, especially in their QMS-governed quality, regulatory, and clinical processes, can unlock efficiencies and drive informed, timely decision making